ANAPTYSBIO, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$98M
Free Cash Flow↑+37360.8% +$98M
$98M
Investing Cash Flow
$74M
Financing Cash Flow↓-109.7% -$15M
$-29M
Capex↓-99.6% -$262K
$1K
Stock Buybacks↑+642.1% +$3M
$3M
Stock-Based Comp↑+3.9% +$322K
$9M
D&A↓-9.7% -$14K
$131K
SBC Allocated Expense↑+3.9% +$322K
$9M